The National Community Pharmacists Association (NCPA) slammed pharmacy benefit managers for pursuing profit over client interests after a report from AARP found retail prices of brand-name drugs skyrocketed in 2009.
AARP's analysis of prescription drug retail price trends found while manufacturer prices for widely used brand-name drugs increased 9.3 percent in 2009, retail prices for the same drugs climbed nearly as quickly at 8.3 percent, and by 41.5 percent over the past five years – rates well in excess of inflation.
All but six of the 217 brand name prescription drugs studied by AARP had retail price increases exceeding general inflation last year. Each of the top 25-selling brand-name drugs had price increases, with most jumping more than five percent.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
